Challenges for synthesising data in a network of registries for systemic psoriasis therapies.
Standard
Challenges for synthesising data in a network of registries for systemic psoriasis therapies. / Ormerod, A D; Augustin, Matthias; Baker, C; Chosidow, O; Cohen, A D; Dam, T N; Garcia-Doval, I; Lecluse, L L; Schmitt-Egenolf, M; Spuls, P I; Watson, K D; Naldi, L.
in: DERMATOLOGY, Jahrgang 224, Nr. 3, 3, 2012, S. 236-243.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Challenges for synthesising data in a network of registries for systemic psoriasis therapies.
AU - Ormerod, A D
AU - Augustin, Matthias
AU - Baker, C
AU - Chosidow, O
AU - Cohen, A D
AU - Dam, T N
AU - Garcia-Doval, I
AU - Lecluse, L L
AU - Schmitt-Egenolf, M
AU - Spuls, P I
AU - Watson, K D
AU - Naldi, L
PY - 2012
Y1 - 2012
N2 - Large disease registries are the preferred method to assess long-term treatment safety. If psoriasis registries collaborate in a network, their power to assess safety is increased.
AB - Large disease registries are the preferred method to assess long-term treatment safety. If psoriasis registries collaborate in a network, their power to assess safety is increased.
KW - Adult
KW - Humans
KW - Male
KW - Female
KW - Middle Aged
KW - Severity of Illness Index
KW - Prospective Studies
KW - Treatment Outcome
KW - Dermatologic Agents/therapeutic use
KW - Biological Agents/therapeutic use
KW - Psoriasis/diagnosis/drug therapy/epidemiology
KW - Registries/standards/statistics & numerical data
KW - Adult
KW - Humans
KW - Male
KW - Female
KW - Middle Aged
KW - Severity of Illness Index
KW - Prospective Studies
KW - Treatment Outcome
KW - Dermatologic Agents/therapeutic use
KW - Biological Agents/therapeutic use
KW - Psoriasis/diagnosis/drug therapy/epidemiology
KW - Registries/standards/statistics & numerical data
M3 - SCORING: Journal article
VL - 224
SP - 236
EP - 243
JO - DERMATOLOGY
JF - DERMATOLOGY
SN - 1018-8665
IS - 3
M1 - 3
ER -